Bicycle Therapeutics (BCYC) Receivables - Net (2018 - 2025)

Bicycle Therapeutics' Receivables - Net history runs 8 years deep, the most recent figure standing at $136000.0 for Q1 2025.

• Quarterly Receivables - Net changed N/A year-over-year to $136000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $136000.0 (changed N/A YoY) and the FY2022 annual result came in at $2.0 million, up 104.5% from the prior year.
• Receivables - Net was $136000.0 for Q1 2025 at Bicycle Therapeutics, down from $233000.0 in the prior quarter.
• Across five years, Receivables - Net topped out at $50.0 million in Q1 2023 and bottomed at $136000.0 in Q1 2025.
• A 5-year average of $13.8 million and a median of $2.0 million in 2021 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2023 — Receivables - Net soared 350.9% — and 2024, when it plunged 99.48%.
• Bicycle Therapeutics' Receivables - Net stood at $1.0 million in 2021, then soared by 104.5% to $2.0 million in 2022, then jumped by 2104.89% to $45.1 million in 2023, then plunged by 99.48% to $233000.0 in 2024, then sank by 41.63% to $136000.0 in 2025.
• Business Quant data shows BCYC's Receivables - Net at $136000.0 in Q1 2025, $233000.0 in Q2 2024, and $45.1 million in Q2 2023.